Skip to main content Accessibility help
  • Print publication year: 2016
  • Online publication date: June 2016

Chapter 22 - Cardiac surgery

from Section 4 - The clinical setting

Related content

Powered by UNSILO
1.Mariscalco, G, Musumeci, F. Fluid management in the cardiothoracic intensive care unit: diuresis–diuretics and hemofiltration. Curr Opin Anaesthesiol 2014; 27: 133–9.
2.Jakob, SM, Ruokonen, E, Takala, J. Assessment of the adequacy of systemic and regional perfusion after cardiac surgery. Br J Anaesth 2000; 84: 571–7.
3.Habicher, M, Perrino, A, Spies, CD, et al. Contemporary fluid management in cardiac anesthesia. J Cardiothorac Vasc Anesth 2011; 25: 1141–53.
4.Assaad, S, Popescu, W, Perrino, A. Fluid management in thoracic surgery. Curr Opin Anaesthesiol 2013; 26: 31–9.
5.Grocott, MPW, Mythen, MG, Gan, TJ. Perioperative fluid management and clinical outcomes. Anesth Analg 2005; 100: 1093–106.
6.Jacob, M, Bruegger, D, Rehm, M, et al. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006; 104: 1223–31.
7.Bruegger, D, Jacob, M, Rehm, M, et al. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol 2005; 289: H1993–9.
8.Rehm, M, Bruegger, D, Christ, F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896–906.
9.Bruegger, D, Schwartz, L, Chappell, D, et al. Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on- and off-pump coronary artery bypass surgery. Basic Res Cardiol 2011; 106: 1111–21.
10.Chappell, D, Hofmann-Kiefer, K, Jacob, M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009; 104: 7889.
11.Berg, S, Engman, A, Hesselvik, JF Laurent, TC. Crystalloid infusion increases plasma hyaluronan. Crit Care Med 1994; 22: 1563–7.
12.Ueda, S, Nishio, K, Akai, Y, et al. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 2006; 26: 134–9.
13.Bark, BP, Persson, J, Grande, PO. Importance of the infusion rate for the plasma expanding effect of 5% albumin, 6% HES 130/0.4, 4% gelatin, and 0.9% NaCl in the septic rat. Crit Care Med 2013; 41: 857–66.
14.Rehberg, S, Yamamoto, Y, Sousse, L, et al. Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis. Am J Physiol Heart Circ Physiol 2012; 303: H1245–54.
15.Woodcock, TE, Woodcock, TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012; 108: 384–94.
16.Levick, JR, Michel, CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87: 198210.
17.Nicholson, JP, Wolmarans, MR, Park, GR. The role of albumin in critical illness. Br J Anaesth 2000; 85: 599610.
18.Finfer, S, Bellomo, R, Boyce, N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247–56.
19.Maitland, K, Kiguli, S, Opoka, RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364: 2483–95.
20.Caironi, P, Tognoni, G, Masson, S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014; 370: 1412–21.
21.van Rijen, EA, Ward, JJ, Little, RA. Effects of colloidal resuscitation fluids on reticuloendothelial function and resistance to infection after hemorrhage. Clin Diagn Lab Immunol 1998; 5: 543–9.
22.Schramko, A, Suojaranta-Ylinen, R, Kuitunen, A, et al. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 2010; 104: 691–7.
23.Nielsen, VG. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions. Blood Coagul Fibrinolysis 2007; 18: 647–56.
24.Ertmer, C, Rehberg, S, van Aken, H, Westphal, M. Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol 2009; 23: 193212.
25.Ljungstrom, KG. Safety of dextran in relation to other colloids-ten years experience with hapten inhibition. Infusionsther Transfusionsmed 1993; 20: 206–10.
26.Guidet, B, Soni, N, Della Rocca, G, et al. A balanced view of balanced solutions. Crit Care 2010; 14: 325. Felippe, J, Timoner, J, Velasco, IT, Lopes, OU, Rocha-e-Silva, M. Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections. Lancet 1980; 2: 1002–4.
28.Strandvik, GF. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia 2009; 64: 9901003.
29.Tisherman, SA, Schmicker, RH, Brase, KJ, et al. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium. Ann Surg 2015; 261: 586–90.
30.Smorenberg, A, Ince, C, Groeneveld, AJ. Dose and type of crystalloid fluid therapy in adult hospitalized patients. Perioper Med (Lond) 2013; 2: 17.
31.Myburgh, JA, Finfer, S, Bellomo, R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901–11.
32.Perner, A, Haase, N, Guttormsen, AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124–34.
33.James, MF, Michell, WL, Joubert, IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107: 693702.
34.Siegemend, M. BaSES trial: Basel Starch Evaluation in Sepsis. ClinicalTrialsgov Identifier. NCT00273728 2013.
35.Annane, D, Siami, S, Jaber, S, et al. Effects of fluid resuscitation with colloids vs. crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013; 310: 1809–17.
36.O'Malley, CM, Frumento, RJ, Hardy, MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100: 1518–24.
37.Waters, JH, Gottlieb, A, Schoenwald, P, et al. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001; 93: 817–22.
38.Meybohm, P, van Aken, H, De Gasperi, A, et al. Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients – a multidisciplinary statement. Crit Care 2013; 17: R166.
39.Ghijselings, I, Rex, S. Hydroxyethyl starches in the perioperative period. A review on the efficacy and safety of starch solutions. Acta Anaesthesiol Belg 2014; 65: 922.
40.Teixeira, C, Garzotto, F, Piccinni, P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013; 17: R14.
41.Qureshi, SH, Rizvi, SI, Patel, NN, Murphy, GJ. Meta-analysis of colloids versus crystalloids in critically ill, trauma and surgical patients. Br J Surg 2016; 103: 1426. doi: 10.1002/bjs. 9943.